Corticotropin releasing hormone receptor 2 antagonist, RQ-00490721, for the prevention of pressure overload-induced cardiac dysfunction.

Mori Y, Tsuchihira A, Yoshida T, Yoshida S, Fujiuchi A, Ohmi M, Isogai Y, Sakaguchi T, Eguchi S, Tsuda T, Kato K, Ohashi K, Ouchi N, Park HM, Murohara T, Takefuji M

Open source

DOI
10.1016/j.biopha.2021.112566
Published
2022 Feb
Container
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.biopha.2021.112566,
  title = {Corticotropin releasing hormone receptor 2 antagonist, RQ-00490721, for the prevention of pressure overload-induced cardiac dysfunction.},
  author = {Mori Y and Tsuchihira A and Yoshida T and Yoshida S and Fujiuchi A and Ohmi M and Isogai Y and Sakaguchi T and Eguchi S and Tsuda T and Kato K and Ohashi K and Ouchi N and Park HM and Murohara T and Takefuji M},
  year = {2022},
  journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  doi = {10.1016/j.biopha.2021.112566},
  url = {https://doi.org/10.1016/j.biopha.2021.112566}
}

RIS

TY  - JOUR
TI  - Corticotropin releasing hormone receptor 2 antagonist, RQ-00490721, for the prevention of pressure overload-induced cardiac dysfunction.
AU  - Mori Y
AU  - Tsuchihira A
AU  - Yoshida T
AU  - Yoshida S
AU  - Fujiuchi A
AU  - Ohmi M
AU  - Isogai Y
AU  - Sakaguchi T
AU  - Eguchi S
AU  - Tsuda T
AU  - Kato K
AU  - Ohashi K
AU  - Ouchi N
AU  - Park HM
AU  - Murohara T
AU  - Takefuji M
PY  - 2022
JO  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
DO  - 10.1016/j.biopha.2021.112566
UR  - https://doi.org/10.1016/j.biopha.2021.112566
ER  - 

APA

Y, M., A, T., T, Y., S, Y., A, F., M, O., Y, I., T, S., S, E., T, T., K, K., K, O., N, O., HM, P., T, M., & M, T. (2022). Corticotropin releasing hormone receptor 2 antagonist, RQ-00490721, for the prevention of pressure overload-induced cardiac dysfunction.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2021.112566

Source records